Protease-activated receptor 2 deficient mice develop less angiotensin II induced left ventricular hypertrophy but more cardiac fibrosis.
<h4>Aims</h4>Activation of Protease Activated Receptor 2 (PAR2) has been shown to be involved in regulation of injury-related processes including inflammation, fibrosis and hypertrophy. In this study we will investigate the role of PAR2 in cardiac injury in a mouse model of hypertension...
Saved in:
| Main Authors: | Albrecht Meyer Zu Schwabedissen, Silvia Vergarajauregui, Marko Bertog, Kerstin Amann, Felix B Engel, Christoph Daniel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0310095 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01) -
Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists
by: M. D. Smirnova, et al.
Published: (2007-12-01) -
Transplantation of cardiac allografts with left ventricular hypertrophy 1.5 cm and more
by: V. N. Poptsov, et al.
Published: (2019-05-01) -
Left ventricular hypertrophy in young hypertensives: the possible crosstalk of mTOR and angiotensin-II -a case-control study
by: Busayo Onafowoke Oguntola, et al.
Published: (2025-01-01) -
Mesenchymal stem cells may alleviate angiotensin II-induced myocardial fibrosis and hypertrophy by upregulating SFRS3 expression
by: Ling Gu, et al.
Published: (2024-12-01)